Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia

1 clinical trials · Condition

Record	Firm	Date
Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia (NCT02577094)	Nantes University Hospital

Every clearance here is in the API, with alerts when new ones post.